Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin

Confused About Mammogram Screening Guidelines?

Given the disparity in mammography guidelines, it can be a challenge to explain why and what the most appropriate screening protocol is for a patient

Mammogram Guidelines for Dense breast tissue

Dense breast tissue categories include fatty, scattered fibroglandular density, heterogeneously dense and extremely dense.

JoAnn Pushkin

JoAnn Pushkin

comparison for breast screening guidelines and mammography guidelines

This chart shows a comparison for breast screening guidelines.

Breast cancer screening and mammography screening guidelines

Breast cancer screening guidelines, a comparison by mammography interval.

If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club. When should mammography screening begin? How often is screening necessary? When should screening end? The varying national breast screening guidelines may have both patients and health providers uncertain as to appropriate recommendations. As the screening guideline discussion is one which has found traction in the news and on social media, it may be a challenge to address a patient’s questions about why her own screening protocol differs from what she may be hearing.

In January 2016, and with much media attention, the U.S. Preventive Service Task Force (USPSTF) issued its final breast cancer screening recommendations. These recommendations differ from those of several national health organizations and have generated confusion and conflicting messaging on the topic within the public arena. Since the USPSTF final guidelines were issued — which recommend screening begin at age 50 and at two-year intervals — the American College of Radiology/Society of Breast Imaging (ACR/SBI), the American Cancer Society (ACS) and the American Congress of Obstetricians and Gynecologists (ACOG) have also updated their own recommendations.

To assist with an analysis of the guideline recommendations, DenseBreast-info.org developed the Breast Cancer Screening Guideline Comparison. Note that the ACS now recommends screening starting at age 45 with an option to start at 40, while ACOG recommends offering screening starting at age 40 but not later than 50. The ACR/SBI, American Medical Association (AMA) and National Comprehensive Cancer Network (NCCN) continue to recommend screening beginning at age 40 and continuing at an annual interval. The ACS suggests mammography interval annually for ages 45-54, and every one to two years at age 55 and older, while ACOG suggests every one to two years without age qualifiers.

The age to stop mammography also differs among guidelines and varies from a specific age cutoff (USPSTF suggests 74 years of age, ACOG suggests age 75 and then shared decision making), to stopping when life expectancy is less than 10 years (ACS), to no specified age limit with recommendation tailored to the individual patient’s health status (ACR/SBI). The AMA and NCCN do not state an age to stop mammography screening.

In light of the growing availability and utilization of 3-D mammography (also known as tomosynthesis), several guidelines also include their view on the technology’s benefits, and these also differ. The ACR/SBI, ACS and NCCN find it an “improvement” over 2-D mammography in terms of detection and recall. Because the USPSTF only considers data from randomized trials with mortality as an endpoint, and there are no such trials of any breast imaging other than mammography, USPSTF’s position is that there is still “insufficient evidence to support routine use.” The ACOG and the AMA do not state positions on 3-D.

Given the disparity in the guidelines, it can be a challenge to explain why and what the most appropriate screening protocol is for a patient. DenseBreast-info.org believes that patients should start their screening mammograms before age 45 for the following reasons:

• The entire reason we screen for breast cancer is to find it early, when most treatable and survivable.

• Breast cancer is the No. 1 cause of death in women aged 35 to 54 years.

• Mammography has been proven to reduce deaths due to breast cancer in women screened beginning at age 40.

• 25 percent of all years of life lost to breast cancer occur in women diagnosed before the age of 45.

• Women at “high risk” for breast cancer due to known or suspected disease-causing mutation (such as BRCA1 or BRCA2) should begin screening at least by age 30, to include magnetic resonance imaging (MRI).

 

The American College of Radiology also recommends annual MRI in addition to mammography in women determined to be at “higher than average risk,” which includes all women diagnosed with breast cancer at/by age 50 and women diagnosed at any age with a personal history of breast cancer and dense breasts.1

 

What about false positives?

• About 10 percent of women having a screening mammogram will be called back for extra testing or views. This is normal. Among women called back, 95 percent do not have cancer. If a needle biopsy is necessary, even that is a simple test.

• The newer technique of 3-D mammography (tomosynthesis) is better able to show cancer and results in fewer callbacks for extra testing.

 

What about screening in dense breasts?

• Younger women are more likely to have dense breast tissue, which can hide cancer on mammography.

• In women who have breasts categorized as “dense” (heterogeneously dense or extremely dense), adding screening ultrasound (if the woman is not a high risk) after a mammogram (2-D or 3-D) can help find more breast cancers. Because ultrasound detects more areas that need follow-up, there is more to check. Ultrasound also increases the chance of needing a needle biopsy to determine if something detected is cancerous or not.

 

Reference

1. Monticciolo DL et al. J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414.doi: 10.1016/j. jacr.2017.11.034. Epub 2018 Jan 19.

 

JoAnn Pushkin is executive director of DenseBreast-info, Inc. For more information on breast screening, risk factors and dense breasts, visit DenseBreast-info.org.

© DenseBreast-info Inc. and JoAnn Pushkin

Related Content

Smoking is strongly linked to lower use of cancer screening services by women, and more advanced disease once cancer is diagnosed, reveals research published in the online journal BMJ Open.

Getty Images

News | Lung Imaging | August 14, 2020
August 14, 2020 — Smoking is strongly linked to lower use of...
Results of Journal of the American College of Surgeons study should reassure breast cancer patients who experienced surgical postponements due to COVID-19 pandemic

Association between Time to Operation and Pathological Stage in DCIS & ER+ Breast Cancer. Courtesy of American College of Surgeons

News | Women's Health | August 07, 2020
August 7, 2020 — A new br...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their annual mammograms now that healthcare facilities across the nation are re-opening their doors following closures due to the COVID-19 pandemic.

Nine-time GRAMMY Award winner and breast cancer survivor Sheryl Crow has served as the spokesperson for Hologic’s Genius 3D Mammography exam for nearly five years.

News | Breast Imaging | August 03, 2020
August 3, 2020 — Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their ann
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.